Patents by Inventor Litao Zhang

Litao Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220309214
    Abstract: The present invention relates to a CFD numerical simulation based fluid equipment resistance optimization algorithm, including the following steps: establishing a fluid equipment unit library; establishing CFD models of fluid equipment units in the fluid equipment unit library, and obtaining a correspondence between a flow rate and a resistance of each fluid equipment unit based on a CFD model of the fluid equipment unit; obtaining fluid equipment units that constitute to-be-tested fluid equipment, and a quantity and a connection sequence of the fluid equipment units; calculating a resistance of each fluid equipment unit based on a flow rate and a correspondence between the flow rate and the resistance of each fluid equipment unit; and adding up resistances of the fluid equipment units in the to-be-tested fluid equipment based on their connection sequence, to obtain a resistance of the to-be-tested fluid equipment.
    Type: Application
    Filed: March 28, 2021
    Publication date: September 29, 2022
    Inventors: Litao Zhang, Yingchao Zhao, Yongwei Zhou, Yifan Zhang, Xin Liao, Erbao Feng
  • Patent number: 11217151
    Abstract: A pixel circuit, an array substrate, and a display panel. The pixel circuit includes an initializing device, a data writing device, a control device, and a current supplementing device. In a light-emitting phase of a driving period of the pixel circuit, a control signal controls the control device to generate a first driving current, and controls the current supplementing device to generate a second driving current. The first driving current and the second driving current are transmitted to a light-emitting unit, and drive the light-emitting unit together for light emission. Currents flowing through the control device and the current supplementing device, respectively, are reduced while meeting a requirement of providing a large driving current to the light-emitting unit. A control capability of the pixel unit on a current of the light-emitting unit is less likely to be weakened, and a display effect is improved.
    Type: Grant
    Filed: August 31, 2020
    Date of Patent: January 4, 2022
    Assignee: WUHAN TIANMA MICRO-ELECTRONICS CO., LTD.
    Inventors: Litao Zhang, Dongliang Dun, Zhiqiang Xia, Ruiyuan Zhou
  • Publication number: 20200402449
    Abstract: A pixel circuit, an array substrate, and a display panel. The pixel circuit includes an initializing device, a data writing device, a control device, and a current supplementing device. In a light-emitting phase of a driving period of the pixel circuit, a control signal controls the control device to generate a first driving current, and controls the current supplementing device to generate a second driving current. The first driving current and the second driving current are transmitted to a light-emitting unit, and drive the light-emitting unit together for light emission. Currents flowing through the control device and the current supplementing device, respectively, are reduced while meeting a requirement of providing a large driving current to the light-emitting unit. A control capability of the pixel unit on a current of the light-emitting unit is less likely to be weakened, and a display effect is improved.
    Type: Application
    Filed: August 31, 2020
    Publication date: December 24, 2020
    Inventors: Litao Zhang, Dongliang Dun, Zhiqiang Xia, Ruiyuan Zhou
  • Publication number: 20170370929
    Abstract: Described are the discovery, synthesis and pharmacological characterization of ?-opioid receptor-selective positive allosteric modulators (? PAMs). These ? PAMs may increase the affinity and/or efficacy of the orthosteric agonists leu-enkephalin and SNC80, as measured by ?-arrestin recruitment and adenylyl cyclase inhibition. The compounds may be useful pharmacological tools to probe the molecular pharmacology of the ? receptor and to explore the therapeutic potential of ? PAMs in diseases such as chronic pain and depression.
    Type: Application
    Filed: December 17, 2015
    Publication date: December 28, 2017
    Inventors: Neil T. Burford, Ying Han, Martyn N. Banks, Litao Zhang, Samuel Gerritz, Andrew Alt
  • Patent number: 7041451
    Abstract: The present invention relates to electrochemiluminescent assays for detecting helicase activity. The invention provides a helicase assay that is rapid, sensitive and suitable for high throughput screening for helicase inhibitors. Helicase inhibitors represent a class of pharmacological agents useful for the treatment of disease.
    Type: Grant
    Filed: June 28, 2002
    Date of Patent: May 9, 2006
    Assignee: sanofi-aventis
    Inventors: Litao Zhang, Richard K Harrison
  • Patent number: 7005440
    Abstract: The use of triaryl acid derivatives of formula (I) and their pharmaceutical compositions as PPAR ligand receptor binders. The PPAR ligand receptor binders of this invention are useful as agonists or antagonists of the PPAR receptor.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: February 28, 2006
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Zaid Jayyosi, Gerard M. McGeehan, Michael F. Kelley, Richard F. Labaudiniere, Litao Zhang, Robert D. Groneberg, Daniel G. McGarry, Thomas J. Caulfield, Anne Minnich, Mark Bobko, Robert Morris
  • Patent number: 6635655
    Abstract: The use of diaryl acid derivatives of formula (I) or pharmaceutically acceptable salts, N-oxides, hydrates or solvates thereof, wherein the variables shown are defined in the disclosure, and their pharmaceutical compositions as PPAR ligand receptor binders. The PPAR ligand receptor binders of this invention are useful as agonists or antagonists of the PPAR receptor.
    Type: Grant
    Filed: September 14, 2000
    Date of Patent: October 21, 2003
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Zaid Jayyosi, Gerard M. McGeehan, Michael F. Kelley, Richard F. Labaudiniere, Litao Zhang, Robert D. Groneberg, Daniel G. McGarry, Thomas J. Caulfield, Anne Minnich, Mark Bobko
  • Publication number: 20030032041
    Abstract: The present invention relates to electrochemiluminescent assays for detecting helicase activity. The invention provides a helicase assay that is rapid, sensitive and suitable for high throughput screening for helicase inhibitors. Helicase inhibitors represent a class of pharmacological agents useful for the treatment of disease.
    Type: Application
    Filed: June 28, 2002
    Publication date: February 13, 2003
    Inventors: Litao Zhang, Richard K. Harrison
  • Publication number: 20020127549
    Abstract: The present invention relates to electorchemiluminescent assays for detecting helicase activity. The invention provides a helicase assay that is rapid, sensitive and suitable for high throughput screening for helicase inhibitors. Helicase inhibitors represent a class of pharmacological agents useful for the treatment of disease.
    Type: Application
    Filed: October 5, 1999
    Publication date: September 12, 2002
    Inventors: LITAO ZHANG, RICHARD K. HARRISON
  • Patent number: 6448004
    Abstract: The present invention relates to electorochemiluminescent assays for detecting helicase activity. The invention provides a helicase assay that is rapid, sensitive and suitable for high throughput screening for helicase inhibitors. Helicase inhibitors represent a class of pharmacological agents useful for the treatment of disease.
    Type: Grant
    Filed: October 5, 1999
    Date of Patent: September 10, 2002
    Assignee: Aventis Pharmaceuticals Inc.
    Inventors: Litao Zhang, Richard K. Harrison
  • Patent number: RE40558
    Abstract: The use of diaryl acid derivatives of formula (I) or pharmaceutically acceptable salts, N-oxides, hydrates or solvates thereof, wherein the variables shown are defined in the disclosure, and their pharmaceutical compositions as PPAR ligand receptor binders. The PPAR ligand receptor binders of this invention are useful as agonists or antagonists of the PPAR receptor.
    Type: Grant
    Filed: October 20, 2005
    Date of Patent: October 28, 2008
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Zaid Jayyosi, Gerard M. McGeehan, Michael F. Kelley, Richard F. Labaudiniere, Litao Zhang, Robert D. Groneberg, Daniel G. McGarry, Thomas J. Caulfield, Anne Minnich, Mark Bobko